SyntekaBio

SyntekaBio Dividend Yield

Dividend Yield of SyntekaBio (226330.KQ) as of Oct 19, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of SyntekaBio is 2026 - . Dividend Yield of SyntekaBio was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SyntekaBio Stock analysis

What does SyntekaBio do? SyntekaBio Inc., headquartered in Daejeon, South Korea, operates in the Health Care sector as a bioinformatics company. Founded in 2019, it provides AI-driven software solutions including the PMAP platform for genetic disease diagnosis and biomarker treatment selection. The company offers clinical trial modeling, genome analysis, and AI-based drug development services for immuno-cancer therapies. With 48 employees, it serves clients in healthcare and pharmaceutical research. SyntekaBio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SyntekaBio stock

On Eulerpool you can find the complete historical development of Dividend Yield SyntekaBio since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's SyntekaBio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — SyntekaBio

All Key Metrics — SyntekaBio